Surface coatings: general issues for consideration regarding parenteral administration of coated nanomedicine products
| Current effective version |
 Reflection paper
|
| Reference number | EMA/325027/2013 |
| Published | 15/08/2013 |
| Keywords | Surface coating, nanomedicines, non-clinical, drug development |
| Description | This document highlights issues that require consideration during the development and lifecycle of coated nanomedicine products designed for parenteral administration. |